|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 27/02 | |
| A61K 47/60 | |||
| A61K 38/17 |
| (11) | Number of the document | 2846836 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13723356.5 |
| Date of filing the European patent application | 2013-05-06 | |
| (97) | Date of publication of the European application | 2015-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/039619 |
| Date | 2013-05-06 |
| (87) | Number | WO 2013/169614 |
| Date | 2013-11-14 |
| (30) | Number | Date | Country code |
| 201261643878 P | 2012-05-07 | US | |
| 201261728017 P | 2012-11-19 | US | |
| 201261731238 P | 2012-11-29 | US |
| (72) |
HOHMAN, Thomas C., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | METHOD OF TREATING AMD IN PATIENTS REFRACTORY TO ANTI-VEGF THERAPY |
| METHOD OF TREATING AMD IN PATIENTS REFRACTORY TO ANTI-VEGF THERAPY |